Tranylcypromine | |||
---|---|---|---|
Synonyms | SKF-385, transamine | ||
Brand names | Parnate | ||
IUPAC name |
| ||
ChemSpider |
None | ||
DrugBank | |||
PubChem | |||
PDB fields |
N/A | ||
Formula |
C9H11N | ||
InChI |
| ||
InChIKey |
| ||
SMILES |
(1R,2S)-stereoisomer |
SMILES | |
C1[C@H]([C@@H]1N)C2=CC=CC=C2
|
Jmol 3D structure
(1S,2R)-stereoisomer
{| class = "mw-collapsible mw-collapsed wikitable"
| SMILES |-
|
C1[C@@H]([C@H]1N)C2=CC=CC=C2
|}
Jmol 3D structure
|-
! Mol. mass | 133.19034 g/mol |-
|-
|-
|-
|-
|-
|-
|-
|}
Tranylcypromine is a substituted amfetamine irreversible monoamine oxidase inhibitor that is used in the management of depression.[1]
External links[]
- NCBI Bookshelf provides free book resources on this topic.
- PubMed provides review articles from the past five years (limit to free review articles or to systematic reviews)
- The TRIP database provides clinical publications about evidence-based medicine.
Reference list[]
- ↑ Frieling, H; Bleich, S (August 2006). "Tranylcypromine: new perspectives on an "old" drug.". European Archives of Psychiatry and Clinical Neuroscience 256 (5): 268–73. PMID 16927039. doi:10.1007/s00406-006-0660-8.
Antidepressants (ATC: N06A) | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
First-generation |
| ||||||||||||||||||||||||||||||||||
Second-generation |
|